KW-6356
- Generic Name
- KW-6356
- Drug Type
- Small Molecule
Overview
KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.
Background
KW-6356 is a selective antagonist of adenosine A2A receptors developed by Kyowa Kirin.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath